57.77
price down icon3.25%   -1.94
after-market アフターアワーズ: 57.77
loading
前日終値:
$59.71
開ける:
$60
24時間の取引高:
482.16K
Relative Volume:
0.78
時価総額:
$1.68B
収益:
$234.60M
当期純損益:
$-13.23M
株価収益率:
-110.97
EPS:
-0.5206
ネットキャッシュフロー:
$19.61M
1週間 パフォーマンス:
-3.35%
1か月 パフォーマンス:
-1.89%
6か月 パフォーマンス:
+37.03%
1年 パフォーマンス:
+182.63%
1日の値動き範囲:
Value
$57.08
$60.01
1週間の範囲:
Value
$57.08
$62.18
52週間の値動き範囲:
Value
$17.11
$73.30

Anaptysbio Inc Stock (ANAB) Company Profile

Name
名前
Anaptysbio Inc
Name
セクター
Healthcare (1111)
Name
電話
858-362-6295
Name
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
職員
104
Name
Twitter
@anaptysbio
Name
次回の収益日
2026-05-18
Name
最新のSEC提出書
Name
ANAB's Discussions on Twitter

Compare ANAB vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ANAB icon
ANAB
Anaptysbio Inc
57.77 1.74B 234.60M -13.23M 19.61M -0.5206
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
435.93 110.28B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
634.62 66.98B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
808.43 50.15B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
295.50 39.71B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
154.89 32.22B 742.00K -1.37B -1.07B -7.0731

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-07 再開されました UBS Buy
2025-10-13 開始されました Barclays Overweight
2025-06-04 アップグレード H.C. Wainwright Neutral → Buy
2025-02-04 開始されました Wolfe Research Outperform
2024-12-11 ダウングレード H.C. Wainwright Buy → Neutral
2024-12-02 ダウングレード BTIG Research Buy → Neutral
2024-07-22 開始されました H.C. Wainwright Buy
2024-07-19 アップグレード JP Morgan Neutral → Overweight
2024-04-16 開始されました Leerink Partners Outperform
2024-04-11 開始されました Wells Fargo Overweight
2024-03-12 アップグレード Wedbush Neutral → Outperform
2024-02-26 開始されました BTIG Research Buy
2024-02-21 開始されました Stifel Buy
2024-02-16 開始されました Piper Sandler Overweight
2023-05-22 アップグレード JP Morgan Underweight → Neutral
2023-05-18 開始されました TD Cowen Outperform
2023-01-06 ダウングレード Raymond James Outperform → Mkt Perform
2022-11-01 アップグレード Guggenheim Neutral → Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-09-13 ダウングレード Truist Buy → Hold
2022-09-01 開始されました Raymond James Outperform
2022-03-22 ダウングレード Guggenheim Buy → Neutral
2021-06-22 開始されました H.C. Wainwright Buy
2021-05-21 開始されました UBS Neutral
2021-03-16 アップグレード Truist Hold → Buy
2021-03-09 ダウングレード Wedbush Outperform → Neutral
2021-03-08 ダウングレード JP Morgan Overweight → Underweight
2021-02-11 アップグレード JP Morgan Underweight → Overweight
2020-10-27 アップグレード Wedbush Neutral → Outperform
2020-10-14 アップグレード Guggenheim Neutral → Buy
2019-11-08 ダウングレード JP Morgan Overweight → Underweight
2019-11-08 ダウングレード Jefferies Buy → Hold
2019-11-08 ダウングレード SunTrust Buy → Hold
2019-11-08 ダウングレード Wedbush Outperform → Neutral
2019-06-21 ダウングレード Credit Suisse Outperform → Neutral
2019-06-21 ダウングレード Stifel Buy → Hold
2018-12-20 開始されました H.C. Wainwright Buy
2018-11-21 開始されました JP Morgan Overweight
2018-07-19 開始されました Credit Suisse Outperform
2018-04-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2018-03-27 繰り返されました Stifel Buy
2018-03-06 繰り返されました Stifel Buy
2018-02-15 繰り返されました SunTrust Buy
2018-01-23 繰り返されました Credit Suisse Outperform
2017-11-15 開始されました SunTrust Buy
2017-11-09 開始されました Jefferies Buy
2017-10-11 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
すべてを表示

Anaptysbio Inc (ANAB) 最新ニュース

pulisher
May 24, 2026

AnaptysBio (ANAB) may find a bottom soon, here's why you should buy the stock now - MSN

May 24, 2026
pulisher
May 23, 2026

J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $70 - Moomoo

May 23, 2026
pulisher
May 22, 2026

Affiliate sale notice: ANAB (NASDAQ: ANAB) plans 10,000-share sale - Stock Titan

May 22, 2026
pulisher
May 22, 2026

AnaptysBio Inc (ANAB) Stock Price, Quote, News & History - Benzinga

May 22, 2026
pulisher
May 22, 2026

ANAB Technical Analysis | Trend, Signals & Chart Patterns | ANAPTYSBIO INC (NASDAQ:ANAB) - ChartMill

May 22, 2026
pulisher
May 21, 2026

Wall Street analysts see a 38.75% upside in AnaptysBio (ANAB): Can the stock really move this high? - MSN

May 21, 2026
pulisher
May 21, 2026

AnaptysBio (NASDAQ: ANAB) moves fiscal year-end to June 30, 2026 - Stock Titan

May 21, 2026
pulisher
May 21, 2026

[144] ANAPTYSBIO, INC SEC Filing - Stock Titan

May 21, 2026
pulisher
May 21, 2026

Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year? - Yahoo Finance UK

May 21, 2026
pulisher
May 21, 2026

ANAB Stock Price, Quote & Chart | ANAPTYSBIO INC (NASDAQ:ANAB) - ChartMill

May 21, 2026
pulisher
May 21, 2026

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

May 21, 2026
pulisher
May 19, 2026

Dennis Mulroy (ANAB) files to sell 10,000 shares via option exercise - Stock Titan

May 19, 2026
pulisher
May 19, 2026

Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High? - Yahoo Finance

May 19, 2026
pulisher
May 17, 2026

AnaptysBio (ANAB) Valuation After Spin Off And Shift To Royalty Focused Model - Sahm

May 17, 2026
pulisher
May 16, 2026

AnaptysBio (NASDAQ:ANAB) Downgraded to "Hold" Rating by Wall Street Zen - MarketBeat

May 16, 2026
pulisher
May 15, 2026

Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Raises Target Price to $90 - Moomoo

May 15, 2026
pulisher
May 15, 2026

Point72 Group Holds 55,303 ANAB Shares (0.2%) — ANAB (ANAB) - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Sirenia Capital discloses 1.92M shares of AnaptysBio (NASDAQ: ANAB) - Stock Titan

May 15, 2026
pulisher
May 15, 2026

Vanguard Group Inc. Increases Position in AnaptysBio, Inc. $ANAB - MarketBeat

May 15, 2026
pulisher
May 15, 2026

Emily Bodnar Reiterates Buy on AnaptysBio, Keeps $30 Price Target on ANB033 Progress and Solid Cash Runway - TipRanks

May 15, 2026
pulisher
May 15, 2026

AnaptysBio appoints Christopher Murphy as CFO - MSN

May 15, 2026
pulisher
May 14, 2026

AnaptysBio: Daniel Faga Is Anticipated to Be the Initial CEO for Spin-Off >ANAB - Moomoo

May 14, 2026
pulisher
May 14, 2026

AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

May 14, 2026
pulisher
May 14, 2026

HighMark Wealth Management LLC Has $4.56 Million Position in AnaptysBio, Inc. $ANAB - MarketBeat

May 14, 2026
pulisher
May 13, 2026

AnaptysBio (ANAB) director Owen Hughes receives 11,250 RSU equity grant - Stock Titan

May 13, 2026
pulisher
May 13, 2026

AnaptysBio (NASDAQ: ANAB) director Hughes Owen files initial Form 3 insider report - Stock Titan

May 13, 2026
pulisher
May 13, 2026

AnaptysBio (NASDAQ: ANAB) grants CFO 25,765 restricted stock units - Stock Titan

May 13, 2026
pulisher
May 13, 2026

AnaptysBio (NASDAQ: ANAB) CFO Christopher Murphy files initial Form 3 - Stock Titan

May 13, 2026
pulisher
May 13, 2026

ANAB Maintained by Barclays -- Price Target Raised to $75.00 - GuruFocus

May 13, 2026
pulisher
May 13, 2026

ANAB Maintained by UBS -- Price Target Raised to $76.00 - GuruFocus

May 13, 2026
pulisher
May 13, 2026

AnaptysBio Faces Pressure As Market Reacts to Update Today - Kalkine Media

May 13, 2026
pulisher
May 13, 2026

UBS Adjusts Price Target on AnaptysBio to $76 From $70, Maintains Buy Rating - Moomoo

May 13, 2026
pulisher
May 13, 2026

A Quick Look at Today's Ratings for AnaptysBio(ANAB.US), With a Forecast Between $75 to $93 - Moomoo

May 13, 2026
pulisher
May 13, 2026

AnaptysBio (NASDAQ:ANAB) Trading Down 7.7% After Earnings Miss - MarketBeat

May 13, 2026
pulisher
May 13, 2026

AnaptysBio stock rallies as Delaware court tosses Tesaro breach claim - MSN

May 13, 2026
pulisher
May 13, 2026

AnaptysBio, Inc. Stock 12‑Month Price Target Raised to $70.54, Implies 8% Upside - TradingView

May 13, 2026
pulisher
May 13, 2026

AnaptysBio, Inc. Stock 12‑Month Price Target Raised to $69.09, Implies 5% Upside - TradingView

May 13, 2026
pulisher
May 13, 2026

TD Cowen Maintains AnaptysBio(ANAB.US) With Buy Rating, Maintains Target Price $75 - Moomoo

May 13, 2026
pulisher
May 13, 2026

AnaptysBio (ANAB) Swings Back To Q1 Loss Per Share Challenging Recent Profitability Hopes - Sahm

May 13, 2026
pulisher
May 13, 2026

ANAB SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus

May 13, 2026
pulisher
May 12, 2026

Anaptys (ANAB) Posts Strong Q1 Revenue Surpassing Expectations - GuruFocus

May 12, 2026
pulisher
May 12, 2026

Nektar Therapeutics Raises $374 Million After Alopecia Data Release; AnaptysBio’s First Tracks Bio Debuts on NASDAQ - geneonline.com

May 12, 2026
pulisher
May 12, 2026

Is AnaptysBio (ANAB) 51.9% Undervalued After Q1 2026 EPS/Revenue - GuruFocus

May 12, 2026
pulisher
May 12, 2026

AnaptysBio (NASDAQ:ANAB) Releases Earnings Results, Misses Expectations By $1.20 EPS - MarketBeat

May 12, 2026
pulisher
May 12, 2026

AnaptysBio, Inc. (ANAB) Misses Q1 EPS by 88c - StreetInsider

May 12, 2026
pulisher
May 12, 2026

AnaptysBio Appoints New CFO and Board Director - The Globe and Mail

May 12, 2026
pulisher
May 12, 2026

AnaptysBio (NASDAQ: ANAB) shifts to royalty focus after Q1 2026 loss - Stock Titan

May 12, 2026
pulisher
May 12, 2026

AnaptysBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 12, 2026
pulisher
May 12, 2026

Earnings Flash (ANAB) AnaptysBio, Inc. Reports Q1 Revenue $25.6M, vs. FactSet Est of $18.9M - marketscreener.com

May 12, 2026
pulisher
May 12, 2026

AnaptysBio (NASDAQ: ANAB) pivots to royalties and launches $100M buyback - Stock Titan

May 12, 2026
pulisher
May 12, 2026

BRIEF-AnaptysBio Q1 Net Income USD -52.884 Million - TradingView

May 12, 2026

Anaptysbio Inc (ANAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$29.66
price down icon 0.98%
$92.25
price up icon 0.12%
$108.87
price up icon 2.48%
$53.86
price down icon 1.17%
ONC ONC
$302.44
price down icon 2.52%
$154.89
price up icon 2.20%
大文字化:     |  ボリューム (24 時間):